BIO-key International, Inc. BKYI
$2.65
-$0.10-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -10.51% | 97.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.51% | 97.96% | |||
| Cost of Revenue | -34.63% | 38.65% | |||
| Gross Profit | -5.38% | 117.77% | |||
| SG&A Expenses | 19.30% | -28.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.35% | -17.59% | |||
| Operating Income | -235.70% | 90.78% | |||
| Income Before Tax | -181.41% | 95.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -181.41% | 95.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -181.41% | 95.22% | |||
| EBIT | -235.70% | 90.78% | |||
| EBITDA | -423.33% | 94.68% | |||
| EPS Basic | -180.77% | 95.71% | |||
| Normalized Basic EPS | -180.78% | 89.61% | |||
| EPS Diluted | -180.77% | 95.71% | |||
| Normalized Diluted EPS | -180.78% | 89.61% | |||
| Average Basic Shares Outstanding | 0.20% | 11.37% | |||
| Average Diluted Shares Outstanding | 0.20% | 11.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||